Company news

Gentian Diagnostics ASA news in 2025

Gentian Diagnostics ASA's news releases, calls and decks from 2025, newest first.

View company

Gentian Diagnostics Says Prioritizes Refinement, Causing Minor Ruo Delay

December 18, 2025

Gentian Diagnostics presents at the DNB Nordic Healthcare Conference

November 25, 2025

Financial calendar

November 11, 2025

GENT: Strong Q3 growth driven by U.S. sales and Cystatin C, with robust margins and advancing R&D

October 23, 2025

Gentian Diagnostics: Invitation to presentation of third quarter results

October 16, 2025

GENT: Q2 revenue up 14% year-over-year; Cystatin C and U.S. sales drive growth despite margin dip

July 10, 2025

Gentian Diagnostics: Invitation to presentation of second quarter results

July 3, 2025

Disclosure of large shareholding

May 22, 2025

GENT: Record sales, high margins, and robust product growth mark a strong Q1 performance

May 7, 2025

Gentian Diagnostics: Notice of annual general meeting

April 11, 2025

GENT: Gentian achieved record profitability, strong growth, and its first-ever dividend proposal

February 12, 2025

Decks in 2025